Clinical Trial Update: Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating the safety and tolerability of combining sorafenib with radiation therapy in patients with brain metastases or primary brai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Tumors

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Brain Metastases, Primary Brain Tumors | Phase 1 | Status: COMPLETED